
Research Stack
The Shred
Metabolic optimization and fat loss
A research stack targeting multiple metabolic pathways. Semaglutide is the most studied GLP-1 receptor agonist, AOD-9604 is a lipolytic fragment of growth hormone, and 5-Amino-1MQ inhibits NNMT — an enzyme linked to fat cell expansion.
Included in this Stack
GLP-1 receptor agonist — appetite regulation and glucose metabolism
GH fragment 176-191 — lipolysis without growth effects
NNMT inhibitor — fat cell energy expenditure
Save 10% vs purchasing individually
Research Use Only — Not for human consumption
Why These Peptides Together?
Semaglutide
GLP-1 receptor agonist — appetite regulation and glucose metabolism
AOD-9604
GH fragment 176-191 — lipolysis without growth effects
5-Amino-1MQ
NNMT inhibitor — fat cell energy expenditure
All products are intended solely for lawful laboratory research. Not for human or veterinary consumption.
